Hookipa Pharma Inc Reports Results For The Quarter Ended In March: Earnings Summary

Hookipa Pharma

16/05/2022 14:32

* HOOKIPA Pharma Inc  HOOK.OQ  reported a quarterly adjusted
loss
of 40 cents​​ per share for the quarter ended in March. The mean
expectation of five analysts for the quarter was for a loss
of 24 cents per share.
    * Revenue fell 72.7% to $1.45 million from a year ago; 
analysts
expected $14.53 million. 
    * HOOKIPA Pharma Inc's reported EPS for the quarter was a
loss
of 40 cents​.
    * The mean earnings estimate of analysts had risen by
about 65.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * HOOKIPA Pharma Inc shares had fallen by 39.9% this
quarter and
lost 41.2% so far this year.
    * The company reported a quarterly loss of $17.97 million.
    * Wall Street's median 12-month price target for HOOKIPA
Pharma
Inc is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 16 at 01:32 p.m.  ​All
figures in US dollars unless otherwise stated